Free Trial

Sysmex Co. (OTCMKTS:SSMXY) Sees Significant Increase in Short Interest

Sysmex logo with Medical background

Sysmex Co. (OTCMKTS:SSMXY - Get Free Report) was the target of a significant increase in short interest in January. As of January 31st, there was short interest totalling 19,700 shares, an increase of 143.2% from the January 15th total of 8,100 shares. Based on an average trading volume of 177,300 shares, the short-interest ratio is presently 0.1 days.

Sysmex Stock Down 1.0 %

Shares of SSMXY stock traded down $0.18 during trading on Monday, hitting $17.90. 58,775 shares of the company were exchanged, compared to its average volume of 84,987. The business's 50-day simple moving average is $18.74 and its 200 day simple moving average is $19.06. Sysmex has a twelve month low of $14.38 and a twelve month high of $28.58. The firm has a market capitalization of $11.27 billion, a price-to-earnings ratio of 36.91 and a beta of 0.90. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.42 and a current ratio of 3.19.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last announced its quarterly earnings data on Wednesday, February 12th. The company reported $0.17 EPS for the quarter. As a group, analysts forecast that Sysmex will post 0.57 EPS for the current fiscal year.

About Sysmex

(Get Free Report)

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.

See Also

Should You Invest $1,000 in Sysmex Right Now?

Before you consider Sysmex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sysmex wasn't on the list.

While Sysmex currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines